Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Worst Biotech CEO of 2011 Is ...
TheStreet.com
Friday, December 9, 2011 - 10:57am
tags:
biotech, Mitchell Gold, Dendreon
Future Dividend Growth In Bristol-Myers Squibb Will Be Weak
Seeking Alpha
Friday, December 9, 2011 - 9:41am
tags:
dividends, Bristol-Myers Squibb
FDA finds quality lapses, other serious problems in factory for unavailable J&J cancer drug
Yahoo/AP
Friday, December 9, 2011 - 9:40am
tags:
FDA, JNJ, Doxil
J&J to Pay Pharmacyclics as Much as $975 Million in Cancer Deal
Bloomberg
Friday, December 9, 2011 - 9:39am
tags:
JNJ, Pharmacyclics, PCI-32765, non-Hodgkin's lymphoma
Bayer Birth Control Pill Backed by U.S. Panel Seeking Clarity on Clot Risk
Bloomberg
Friday, December 9, 2011 - 9:38am
tags:
Bayer, birth control pill, Yaz
Sinclair IS Pharma to buy US biotech co for 20 mln stg
Reuters
Thursday, December 8, 2011 - 12:01pm
tags:
Sinclair IS Pharma, M&A, wound care, Advanced Bio-Technologies
Hungry biotechs make better partners for Big Pharma
Fierce Biotech
Thursday, December 8, 2011 - 11:58am
tags:
biotech, Big Pharma, Roche, Zelboraf, vismodegib
New Setback for Avastin as Breast Cancer Treatment
NY Times, NY
Thursday, December 8, 2011 - 11:39am
tags:
breast cancer, Avastin, Roche, Genentech
Who Needs Branded Statins? Not Me, Say Docs
Pharmalot
Thursday, December 8, 2011 - 11:38am
tags:
generics, statins, physicians, Crestor, Lipitor, Pfizer, AstraZeneca
AstraZeneca & Repurposing Drugs: Morris Explains
Pharmalot
Thursday, December 8, 2011 - 11:36am
tags:
AstraZeneca, drug repurposing, Medicines Research Council
3 Biotech Stocks You Should Sell Before 2012
Seeking Alpha
Thursday, December 8, 2011 - 11:34am
tags:
Isis Pharmaceuticals, MannKind, Medivation
Savient's Krystexxa: How I Get A $209 Million Sales Estimate By 2015
Seeking Alpha
Thursday, December 8, 2011 - 11:33am
tags:
Savient, gout, Krystexxa
Affymax Rises After Winning Panel’s Backing for Anemia Drug
Bloomberg
Thursday, December 8, 2011 - 11:32am
tags:
anemia, FDA, advisory panels, Affymax, peginesatide
Why Perifosine Phase 3 Trials Will Likely Fail
Seeking Alpha
Thursday, December 8, 2011 - 11:26am
tags:
perifosine, Keryx, Aeterna Zentaris, colon cancer
Amgen expects to acquire 83.3M shares in buyback
Yahoo/AP
Thursday, December 8, 2011 - 11:25am
tags:
stock buyback, Amgen
Merck Asked by U.K. Agency for More Tests of Smoker’s Cough Drug
Bloomberg
Thursday, December 8, 2011 - 11:23am
tags:
smoker's cough, Merck, UK, NICE, Daxas
Alexza Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review Finds
Bloomberg
Thursday, December 8, 2011 - 11:22am
tags:
Alexza, antipsychotics, FDA, Adasuve
6 Buffett-Friendly Pharmaceutical Stocks
Seeking Alpha
Thursday, December 8, 2011 - 11:19am
tags:
Abbott Laboratories, Warren Buffett, Eli Lilly, Merck, Pfizer, Teva Pharmaceuticals, Bristol-Myers Squibb
AstraZeneca digs deeper in China with generics buy
Reuters
Thursday, December 8, 2011 - 11:17am
tags:
China, generics, AstraZeneca, Guangdong BeiKang, M&A
Dividend Stock Leader Novo Nordisk Keeps Innovating
Investor's Business Daily
Wednesday, December 7, 2011 - 10:15pm
tags:
hemophilia, Novo Nordisk, diabetes, dividends

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.